An effective, less disruptive treatment option
The unparalleled precision and motion synchronization capabilities of the CyberKnife System maximize radiation delivered to the target — while helping minimize the dose to surrounding healthy tissues. The result is a highly effective treatment that eliminates many of the inconveniences of other treatments — and significantly reduces the risk of the side effects that too often disrupt the lives of patients during and after treatment.
In fact, the hypofractionated, high-dose radiosurgery delivered by the CyberKnife System has been shown to improve tumor control and patient survival when compared to conventional radiotherapy.
CYBERKNIFE VS. SURGERY
Treatment with the CyberKnife System is an outpatient procedure that does not requires incisions or general anesthesia. Most patients will not require hospitalization or a long recovery period.
CYBERKNIFE VS. CONVENTIONAL RADIATION THERAPY
CyberKnife treatment is typically completed in as little as 3 to 4 sessions over 1 to 2 weeks, compared to 20 to 30 sessions over 4 to 6 weeks with conventional radiation therapy.
Lung Cancer
Unrivaled precision — where it matters most.
One of the biggest challenges in lung cancer treatment remains effectively treating the cancer, while minimizing impact on the many sensitive tissues and vital organs that surround the lungs. Precision is critical — and that’s what makes the CyberKnife System so unique. The CyberKnife System is the only robotic radiation delivery system that incorporates Synchrony® Respiratory Technology, enabling the system to automatically and continually track and synchronize treatment delivery to motion to keep the radiation precisely targeted on the tumor as it moves with your natural breathing. The CyberKnife System is a leading technology in SBRT, a specialized type of radiation therapy, used to routinely treat lung cancers and metastases. The system provides a proven, non-surgical option for treating early stage, inoperable non-small cell lung cancer, tumors in challenging anatomical locations such as central lung tumors surrounded by sensitive structures and lung tumors near the chest wall, and inoperable peripheral lung tumors. CyberKnife SBRT may also be an option for those patients seeking an alternative to surgery.
Key CyberKnife® treatment benefits
- Radiation treatment is non-surgical and non-invasive
- Good cancer control
- Significantly reduced incidence of common side effects such as shortness of breath, swallowing difficulties or a sore throat
- Treatments are typically completed in as little as 3 to 4 sessions across 1 to 2 weeks
- Most patients can continue normal activity throughout treatment
Potential side effects of CyberKnife® treatment for lung cancer:
Most radiation side effects are minimal and last only a short time.
Ask your doctor for more details about potential side effects associated with your specific radiation therapy treatment.
Managing side effects with your medical team:
Prior to beginning CyberKnife treatment, your medical team will discuss all possible side effects and may prescribe medication to control any side effects, should they occur.
Protecting healthy tissue — protecting quality of life
Despite the higher dose rate associated with SBRT, multiple studies have validated that CyberKnife SBRT is well tolerated with minimal side effects. Unlike any other radiation treatment, the CyberKnife System continually tracks the target and automatically corrects the radiation beam for movement of the tumor in real-time throughout the entire treatment session. With this automatic motion tracking and synchronization, the CyberKnife System enhances your treatment team’s ability to maximize the radiation dose delivered to the target — while minimizing dose to surrounding healthy tissues to reduce side-effects that can impact quality of life both during and after treatment. The majority of patients can continue normal activity during and immediately following treatment.